Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption.
about
Astrocytic Toll-like receptor 3 is associated with ischemic preconditioning-induced protection against brain ischemia in rodentsAntibodies as Mediators of Brain PathologyNeuroprotective Strategies after Neonatal Hypoxic Ischemic EncephalopathyImmune Regulation of Antibody Access to Neuronal TissuesThe MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.Antagonism of peripheral inflammation reduces the severity of status epilepticus.Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis.Peripheral blood AKAP7 expression as an early marker for lymphocyte-mediated post-stroke blood brain barrier disruptionExpression and functional significance of SOCS-1 and SOCS-3 in astrocytesNature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages.Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury.Significance of marrow-derived nicotinamide adenine dinucleotide phosphate oxidase in experimental ischemic stroke.The role of cell type-specific responses in IFN-β therapy of multiple sclerosis.Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.Gene networks specific for innate immunity define post-traumatic stress disorder.Extracellular proteolytic pathophysiology in the neurovascular unit after stroke.Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling.Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells.Cytosolic Receptor Melanoma Differentiation-Associated Protein 5 Mediates Preconditioning-Induced Neuroprotection Against Cerebral Ischemic Injury.The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune diseaseMagnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosisToll-like receptors: novel pharmacological targets for the treatment of neurological diseases.Toll-like receptor signaling in endogenous neuroprotection and stroke.It's all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke neuroprotection.Inflammation and the emerging role of the toll-like receptor system in acute brain ischemia.Does inflammation after stroke affect the developing brain differently than adult brain?Inflammation in adult and neonatal stroke.Toll-like receptor 3 agonist Poly I:C protects against simulated cerebral ischemia in vitro and in vivo.Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.Interferons in the central nervous system: a few instruments play many tunes.Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats.The type I interferon response bridles rabies virus infection and reduces pathogenicity.Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain.Vitreous levels of interleukine-8 and monocyte chemoattractant protein-1 in macular oedema with branch retinal vein occlusion.Long-term effect of high doses glucocorticosteroids on mRNA expression for IL-6 and IL-8 in relapsed multiple sclerosis patients.Effect of interferon-β on neuroinflammation, brain injury and neurological outcome after experimental subarachnoid hemorrhage.Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats.Increased disability and MRI lesions after discontinuation of IFN-beta-1a in secondary progressive MS.
P2860
Q21090615-63922786-8F0E-4B0B-9B6A-31AE7C01B694Q26780374-075BD71A-E3ED-45BA-8B40-4BE5D2C9DA45Q26782756-28065C51-657E-4126-A9DC-B6F09AA17BACQ28733365-F620A5B3-6314-48FB-83D3-D6880CC23EBBQ30476952-BE320DB2-5CA0-4DE9-B152-8338C6FFAD45Q30498265-3BEA6BD2-8BFF-4388-B3E3-5375A81B1843Q33576939-BB746EFB-0970-4484-B577-7CF02735ED41Q33683067-9366DDA0-C614-4663-85E0-6C122B376E88Q33717808-F7590A0B-10C8-46DC-BD42-2CFED941629BQ34339353-1A3228DD-99CC-406B-82ED-14FC86986F9CQ35088789-75F9E4EC-E4CD-496E-BE17-3E116604CE95Q35492103-C7F0E1CF-61ED-4BCA-954C-CA89EC3C7497Q35621233-294F557F-A61B-4932-9AC0-BB3C3858C939Q35962565-1D6312D2-011F-49F5-8009-085325BD0630Q36048222-1D3BF805-42B5-4548-898D-C10D0EC901B9Q36052713-0D0CE532-76B9-4C37-B244-589A114B03B8Q36347457-B16807C4-B064-499B-AD92-689FA676D47BQ36423925-1A901558-14E5-4D25-9E2B-92924DCDCFE9Q36444483-A22CBA03-370D-4352-B9FB-6A7E8943FB24Q36537921-1BED5D73-4847-4A47-BEF9-457CA737AF20Q36839991-81912EBC-BBB2-48ED-BD92-8B5BDD176883Q36987436-4AD765DB-A061-4C6E-8FE6-BF3756E2D2A6Q37171364-022F0BB5-F904-4A3C-A0A1-931FC05581E7Q37259848-1FD0F0DD-3D64-4682-8F10-12825191A00AQ37312320-179CDF82-6CE9-44FE-8F30-452F550C368BQ37466730-E7171F36-DBD8-4282-BFD8-F7584B29C359Q37714376-96582518-A508-477B-8093-A06B52B49E8FQ37728693-4E6EA6AE-3683-49E3-BF49-C3156E550CCDQ38004932-35B52D98-7E7B-4857-876D-24FB83BF0029Q38192651-CC365263-8FFB-4FBA-B33C-636DEB7CAF71Q38931847-5FA20686-52F9-4FC0-A650-EBE80B32CE2CQ39497376-944E54A2-FD96-4D21-832B-1E9156DF7809Q40020998-29F70E3E-53B8-4F5C-AF4D-694B3D8E4222Q42475527-329454C5-E4CB-42E8-8719-2AA075EF0939Q42795549-5823F42E-6353-48E4-A74C-8418E9832EB3Q43181265-3238E7A3-F08D-48B7-9808-D706E4FDE6CBQ43185918-8CD823DC-3B3D-42FE-AC8C-D0268CA6645FQ47999033-0BB7F4A0-81CD-47B4-8125-7C572915695AQ48314697-04700BC4-2F04-4D67-9B45-1040075650D8Q48785648-1AFD9874-DEB5-47BF-9D80-B13B084D494F
P2860
Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Interferon-beta prevents cytok ...... lood-brain barrier disruption.
@en
Interferon-beta prevents cytok ...... lood-brain barrier disruption.
@nl
type
label
Interferon-beta prevents cytok ...... lood-brain barrier disruption.
@en
Interferon-beta prevents cytok ...... lood-brain barrier disruption.
@nl
prefLabel
Interferon-beta prevents cytok ...... lood-brain barrier disruption.
@en
Interferon-beta prevents cytok ...... lood-brain barrier disruption.
@nl
P2093
P2860
P50
P1476
Interferon-beta prevents cytok ...... blood-brain barrier disruption
@en
P2093
Christien D Dijkstra
Peter H van der Meide
Peter R Bär
Sarah Floris
Wouter B Veldhuis
P2860
P304
P356
10.1097/01.WCB.0000080701.47016.24
P577
2003-09-01T00:00:00Z
P5875
P6179
1005203014